Literature DB >> 35080050

Will inhibition of cellular crosstalk resolve liver fibrosis?

Edward N Harris1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35080050      PMCID： PMC9429820          DOI： 10.1002/hep.32361

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.298


× No keyword cloud information.
  11 in total

Review 1.  Angiogenesis in chronic liver disease and its complications.

Authors:  Stephanie Coulon; Femke Heindryckx; Anja Geerts; Christophe Van Steenkiste; Isabelle Colle; Hans Van Vlierberghe
Journal:  Liver Int       Date:  2010-11-15       Impact factor: 5.828

2.  Dietary macronutrients and the aging liver sinusoidal endothelial cell.

Authors:  Victoria Carroll Cogger; Mashani Mohamad; Samantha Marie Solon-Biet; Alistair M Senior; Alessandra Warren; Jennifer Nicole O'Reilly; Bui Thanh Tung; Dmitri Svistounov; Aisling Clare McMahon; Robin Fraser; David Raubenheimer; Andrew J Holmes; Stephen James Simpson; David George Le Couteur
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-02-26       Impact factor: 4.733

Review 3.  Global Epidemiology of Chronic Liver Disease.

Authors:  Shantan Cheemerla; Maya Balakrishnan
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-06-04

4.  LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis.

Authors:  Meng Xu; Hong-Hai Xu; Yuan Lin; Xiangnan Sun; Li-Jing Wang; Zhe-Ping Fang; Xue-Han Su; Xiang-Jing Liang; Yang Hu; Zhi-Min Liu; Yuanxiong Cheng; Yuanyuan Wei; Jiabin Li; Li Li; Hong-Juan Liu; Zhiqiang Cheng; Na Tang; Chao Peng; Tingting Li; Tengfei Liu; Liang Qiao; Dalei Wu; Yan-Qing Ding; Wei-Jie Zhou
Journal:  Cell       Date:  2019-08-29       Impact factor: 41.582

5.  Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver.

Authors:  Akinori Okumura; Hiroyuki Unoki-Kubota; Yumi Matsushita; Tomoko Shiga; Yuriko Moriyoshi; Satoshi Yamagoe; Yasushi Kaburagi
Journal:  Biosci Trends       Date:  2013-12       Impact factor: 2.400

6.  LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance.

Authors:  Fei Lan; Hirofumi Misu; Keita Chikamoto; Hiroaki Takayama; Akihiro Kikuchi; Kensuke Mohri; Noboru Takata; Hiroto Hayashi; Naoto Matsuzawa-Nagata; Yumie Takeshita; Hiroyo Noda; Yukako Matsumoto; Tsuguhito Ota; Toru Nagano; Masatoshi Nakagen; Ken-ichi Miyamoto; Kanako Takatsuki; Toru Seo; Kaito Iwayama; Kunpei Tokuyama; Seiichi Matsugo; Hong Tang; Yoshiro Saito; Satoshi Yamagoe; Shuichi Kaneko; Toshinari Takamura
Journal:  Diabetes       Date:  2014-01-29       Impact factor: 9.461

Review 7.  Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment.

Authors:  Leen J M Heyens; Dana Busschots; Ger H Koek; Geert Robaeys; Sven Francque
Journal:  Front Med (Lausanne)       Date:  2021-04-14

Review 8.  The Endothelium as a Driver of Liver Fibrosis and Regeneration.

Authors:  Erica Lafoz; Maria Ruart; Aina Anton; Anna Oncins; Virginia Hernández-Gea
Journal:  Cells       Date:  2020-04-10       Impact factor: 6.600

9.  A strategy of vascular-targeted therapy for liver fibrosis.

Authors:  Yuan Lin; Meng-Qi Dong; Zhi-Min Liu; Meng Xu; Zhi-Hao Huang; Hong-Juan Liu; Yi Gao; Wei-Jie Zhou
Journal:  Hepatology       Date:  2022-01-16       Impact factor: 17.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.